RCKT News
Archived Headlines
- Week ahead: 12 IPOs feature health care, holdovers and a $500 million health tech IPO 02/09/15
- Week ahead: IPO market set for another surge in the health care sector with 10 IPOs 02/02/15
- Keep an eye on it: Inotek Pharmaceuticals sets terms for $65 million IPO 01/22/15
- A new eye-PO: Glaucoma biotech Inotek Pharmaceuticals files for an $86 million IPO 11/05/14
US IPO Weekly Recap: No IPOs in final week of a challenging February
There were no initial public offerings in the past week, but recent IPO performance continues to trend up. The 24 IPOs in 2015 now average +18%, including +5% after the first day, its highest point this year. A few highlights from February 2015: ...read more
US IPO Weekly Recap: Health IPOs go public or postpone ahead of a busy March
This past week, the set of small health IPOs that had been languishing on the IPO calendar either postponed or went public. • Two small health IPOs raised a...read more
Eye drop IPO Inotek Pharmaceuticals prices IPO at $6 per share
Inotek Pharmaceuticals, a biotech developing a small molecule eye drop therapy to treat glaucoma, raised $40 million by offering 6.7 million shares at $6.00 per share. At the offer price, it commands a fully diluted market value of $96 million. Insiders...read more
Blindness biotech blinks: Inotek Pharmaceuticals slashes proposed IPO valuation by 50%
Inotek Pharmaceuticals, a biotech developing a small molecule eye drop therapy to treat glaucoma, slashed the proposed price of its upcoming IPO on Tuesday. The Lexington, MA-based company now plans to raise $40 million by offering 6.7 million shares at a...read more